BioSpace News Archive

ImmunoGen Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that on April 30, 2020 the compensation committee of the Company’s Board of Directors granted non-qualified stock option awards to purchase an aggregate of 38,300 shares of its common stock to two new employees under the ImmunoGen, Inc.

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release first quarter financial results after market close on Monday, May 11, 2020.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that the distribution date for the previously announced distribution to our stockholders of shares of Hoth Therapeutics, Inc. (“Hoth”) will not be taking place today, May 4, 2020, because of the requirement that the shares be registered prior to distribution.

Veeva Systems (NYSE:VEEV) will announce financial results for its first quarter which ended April 30, 2020 after market close on May 28, 2020.

Oncology Systems gross orders grew 1% in dollars or 2% in constant currency in the quarter; trailing twelve months gross orders grew 5% in dollars or 6% in constant currency

American Renal Associates Holdings, Inc., a leading kidney care and dialysis services provider focused on partnering with local nephrologists, announced that it will release its first quarter 2020 earnings results after the market close on Monday, May 11, 2020, to be followed by a conference call on Tuesday, May 12, 2020 at 9:00 a.m.

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the Company has scheduled the release of its first quarter 2020 financial results after the market closes on Monday, May 11, 2020.

Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs post-market on May 11, 2020.

Illumina (NASDAQ: ILMN) today announced the appointment of Alex Aravanis as Chief Technology Officer.

CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live audio webcast on Monday, May 11, 2020 at 4:30 p.m.